U7F-43858-72112
4 vaccinations
3 coded responses
20 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 804 / CO
- Registered
- 2021-03-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-20
Registered in v-safe
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
-
2021-06-18
Survey response — 3 months, dose 1MedDRA: Fatigue, Nasopharyngitis — Feeling: GoodFree text: Fatigue and mild cold-like symptoms after travel in mid-May. Only lasted a day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-04
Dose 2 — Pfizer-BioNTech
-
2021-09-17
Survey response — 6 months, dose 1MedDRA: Office visit, Surgery, Uterine leiomyoma — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Uterine fibroid · Healthcare visit (other): Doctor visit then surgery to removeMedDRA releases: 2024-11 · check-in free text available
-
2021-09-17
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-21
- 2021-11-05
-
2022-01-28
Dose 3 — Pfizer-BioNTech
- 2022-02-02
-
2022-04-29
Survey response — 3 months, dose 3MedDRA: Biochemical pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: 2 chemical pregnancies in a row, albeit I don't attribute it as having any connection with being vaccinated.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-29
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-03
- 2022-07-31
-
2022-10-20
Dose 4 — Moderna
- 2023-01-30
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Janssen/Johnson & Johnson | |
| 2 | 2021-08-04 | Pfizer-BioNTech | No |
| 3 | 2022-01-28 | Pfizer-BioNTech | No |
| 4 | 2022-10-20 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-17 | Unsuccessful | |
| 2022-04-29 | Unsuccessful |
Free text
Release 9 — 3 months, dose 1
Symptoms: Fatigue and mild cold-like symptoms after travel in mid-May. Only lasted a day.
Release 9 — 6 months, dose 1
Release 11 — 3 months, dose 3
Symptoms: 2 chemical pregnancies in a row, albeit I don't attribute it as having any connection with being vaccinated.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Surgery | · | · | ✓ |
| SD | Biochemical pregnancy | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Uterine leiomyoma | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release